Clinical Trials Logo
NCT number NCT01710098
Study type Observational
Source United Clinic Management GmbH
Contact Leopold Durner, MD
Phone +49-89-85693-0
Email Durner@ukmp.de
Status Recruiting
Phase N/A
Start date June 2012
Completion date June 2014
View Details

Clinical Trial Summary

How are testosterone levels of patients with prostate cancer under treatment with Firmagon® changing.

Former studies showed a quick fall of testosterone levels after start of therapy with Firmagon® and a quick recovery when therapy is stopped. The investigators want to prove this in a normal outpatient urologist setting. Furthermore data is collected to prove the adherence to the German S3-Guideline for the treatment of prostate cancer.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Clinical Trial Details
See also
Status Clinical Trial Phase
 Not yet recruiting NCT02811809 - Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer Phase 2
 Not yet recruiting NCT02840552 - The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer Phase 3
 Not yet recruiting NCT02723734 - Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM N/A
 Not yet recruiting NCT02816840 - PET-CT/MRI in the Radiotherapy for Prostate Cancer Phase 1/Phase 2
 Recruiting NCT02620033 - Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy N/A
 Recruiting NCT02577627 - Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC N/A
 Recruiting NCT02628535 - Safety Study of MGD009 in B7-H3-expressing Tumors Phase 1
 Recruiting NCT02643511 - Hemiablative Focal Brachytherapy Pilot Study Phase 2
 Recruiting NCT02611882 - Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients Phase 1/Phase 2
 Recruiting NCT02551341 - Lung Protective Ventilation During Robotic Assisted Prostatectomy Phase 3
 Recruiting NCT02559115 - 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer Phase 2
 Recruiting NCT02220829 - Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy Phase 3
 Recruiting NCT02600156 - Focal Laser Ablation of Prostate Cancer Tumors N/A
 Recruiting NCT02623933 - MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients N/A
 Recruiting NCT02570919 - Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer Phase 2
 Recruiting NCT02739048 - Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation. N/A
 Recruiting NCT02494921 - LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC Phase 1/Phase 2
 Not yet recruiting NCT02546427 - Hypofractionated Whole Pelvic Radiotherapy of the Prostate Phase 1
 Not yet recruiting NCT02524860 - Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device N/A
 Not yet recruiting NCT02478112 - Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI) N/A